Literature DB >> 26387641

Genetically engineered mouse models for studying inflammatory bowel disease.

Atsushi Mizoguchi1, Takahito Takeuchi1, Hidetomo Himuro1, Toshiyuki Okada1, Emiko Mizoguchi2.   

Abstract

Inflammatory bowel disease (IBD) is a chronic intestinal inflammatory condition that is mediated by very complex mechanisms controlled by genetic, immune, and environmental factors. More than 74 kinds of genetically engineered mouse strains have been established since 1993 for studying IBD. Although mouse models cannot fully reflect human IBD, they have provided significant contributions for not only understanding the mechanism, but also developing new therapeutic means for IBD. Indeed, 20 kinds of genetically engineered mouse models carry the susceptibility genes identified in human IBD, and the functions of some other IBD susceptibility genes have also been dissected out using mouse models. Cutting-edge technologies such as cell-specific and inducible knockout systems, which were recently employed to mouse IBD models, have further enhanced the ability of investigators to provide important and unexpected rationales for developing new therapeutic strategies for IBD. In this review article, we briefly introduce 74 kinds of genetically engineered mouse models that spontaneously develop intestinal inflammation.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  ER stress; IBD susceptibility gene; epithelial barrier; immunoregulation; knockout mice; mouse models

Mesh:

Substances:

Year:  2015        PMID: 26387641      PMCID: PMC4689626          DOI: 10.1002/path.4640

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  127 in total

1.  The production of an experimental ulcerative colitis in rabbits.

Authors:  J B KIRSNER; J ELCHLEPP
Journal:  Trans Assoc Am Physicians       Date:  1957

2.  Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.

Authors:  R B Shaikh; S Santee; S W Granger; K Butrovich; T Cheung; M Kronenberg; H Cheroutre; C F Ware
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

4.  The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice.

Authors:  Yukie Murata; Akira Yamashita; Takashi Saito; Kazuo Sugamura; Junji Hamuro
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

5.  Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice.

Authors:  Kabir S Matharu; Emiko Mizoguchi; Carmen Alonso Cotoner; Deanna D Nguyen; Bethany Mingle; Onyinye I Iweala; Megan E McBee; Andrew T Stefka; Guenolee Prioult; Kevin M Haigis; Atul K Bhan; Scott B Snapper; Hidehiro Murakami; David B Schauer; Hans-Christian Reinecker; Atsushi Mizoguchi; Cathryn R Nagler
Journal:  Gastroenterology       Date:  2009-08-03       Impact factor: 22.682

6.  Deletion of TLR5 results in spontaneous colitis in mice.

Authors:  Matam Vijay-Kumar; Catherine J Sanders; Rebekah T Taylor; Amrita Kumar; Jesse D Aitken; Shanthi V Sitaraman; Andrew S Neish; Satoshi Uematsu; Shizuo Akira; Ifor R Williams; Andrew T Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

8.  Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation.

Authors:  Kris A Steinbrecher; Eleana Harmel-Laws; Raquel Sitcheran; Albert S Baldwin
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

9.  The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.

Authors:  F Meylan; Y-J Song; I Fuss; S Villarreal; E Kahle; I-J Malm; K Acharya; H L Ramos; L Lo; M M Mentink-Kane; T A Wynn; T-S Migone; W Strober; R M Siegel
Journal:  Mucosal Immunol       Date:  2010-10-27       Impact factor: 7.313

10.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Authors:  Carl A Anderson; Gabrielle Boucher; Charlie W Lees; Andre Franke; Mauro D'Amato; Kent D Taylor; James C Lee; Philippe Goyette; Marcin Imielinski; Anna Latiano; Caroline Lagacé; Regan Scott; Leila Amininejad; Suzannah Bumpstead; Leonard Baidoo; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Jean-Frédéric Colombel; Lee A Denson; Martine De Vos; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Rudolf S N Fehrmann; James A B Floyd; Timothy Florin; Denis Franchimont; Lude Franke; Michel Georges; Jürgen Glas; Nicole L Glazer; Stephen L Guthery; Talin Haritunians; Nicholas K Hayward; Jean-Pierre Hugot; Gilles Jobin; Debby Laukens; Ian Lawrance; Marc Lémann; Arie Levine; Cecile Libioulle; Edouard Louis; Dermot P McGovern; Monica Milla; Grant W Montgomery; Katherine I Morley; Craig Mowat; Aylwin Ng; William Newman; Roel A Ophoff; Laura Papi; Orazio Palmieri; Laurent Peyrin-Biroulet; Julián Panés; Anne Phillips; Natalie J Prescott; Deborah D Proctor; Rebecca Roberts; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Philip Schumm; Frank Seibold; Yashoda Sharma; Lisa A Simms; Mark Seielstad; A Hillary Steinhart; Stephan R Targan; Leonard H van den Berg; Morten Vatn; Hein Verspaget; Thomas Walters; Cisca Wijmenga; David C Wilson; Harm-Jan Westra; Ramnik J Xavier; Zhen Z Zhao; Cyriel Y Ponsioen; Vibeke Andersen; Leif Torkvist; Maria Gazouli; Nicholas P Anagnou; Tom H Karlsen; Limas Kupcinskas; Jurgita Sventoraityte; John C Mansfield; Subra Kugathasan; Mark S Silverberg; Jonas Halfvarson; Jerome I Rotter; Christopher G Mathew; Anne M Griffiths; Richard Gearry; Tariq Ahmad; Steven R Brant; Mathias Chamaillard; Jack Satsangi; Judy H Cho; Stefan Schreiber; Mark J Daly; Jeffrey C Barrett; Miles Parkes; Vito Annese; Hakon Hakonarson; Graham Radford-Smith; Richard H Duerr; Séverine Vermeire; Rinse K Weersma; John D Rioux
Journal:  Nat Genet       Date:  2011-02-06       Impact factor: 38.330

View more
  10 in total

Review 1.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.

Authors:  John B Grigg; Gregory F Sonnenberg
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

Review 2.  The roles of estrogen and estrogen receptors in gastrointestinal disease.

Authors:  Changmei Chen; Xiang Gong; Xiaoxu Yang; Xianhui Shang; Qian Du; Qiushi Liao; Rui Xie; Yuanshou Chen; Jingyu Xu
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

3.  Optimisation of Intestinal Fibrosis and Survival in the Mouse S. Typhimurium Model for Anti-fibrotic Drug Discovery and Preclinical Applications.

Authors:  Laura A Johnson; Eva S Rodansky; David S Moons; Scott D Larsen; Richard R Neubig; Peter D R Higgins
Journal:  J Crohns Colitis       Date:  2017-06-01       Impact factor: 9.071

4.  Selenium nanoparticles decorated with Ulva lactuca polysaccharide potentially attenuate colitis by inhibiting NF-κB mediated hyper inflammation.

Authors:  Chenghui Zhu; Shuimei Zhang; Chengwei Song; Yibo Zhang; Qinjie Ling; Peter R Hoffmann; Jun Li; Tianfeng Chen; Wenjie Zheng; Zhi Huang
Journal:  J Nanobiotechnology       Date:  2017-03-07       Impact factor: 10.435

Review 5.  Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models.

Authors:  Emiko Mizoguchi; Daren Low; Yui Ezaki; Toshiyuki Okada
Journal:  Intest Res       Date:  2020-04-20

6.  Influence of Acetylcholine Esterase Inhibitors and Memantine, Clinically Approved for Alzheimer's Dementia Treatment, on Intestinal Properties of the Mouse.

Authors:  Vu Thu Thuy Nguyen; Jason Sallbach; Malena Dos Santos Guilherme; Kristina Endres
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

7.  STAT6 rs324015 Gene Polymorphism Increases Ulcerative Colitis Risk: A Case-Control Study.

Authors:  Lingying Dai; Dan Zhang; Yunzhi Qian; Yemin Wan; Shuchen Chang; Haihua Qian
Journal:  Pharmgenomics Pers Med       Date:  2021-01-19

8.  Glucose promotes regulatory T cell differentiation to maintain intestinal homeostasis.

Authors:  Yu Yu; Wenjing Yang; Tianming Yu; Xiaojing Zhao; Zheng Zhou; Yanbo Yu; Lifeng Xiong; Hui Yang; Anthony J Bilotta; Suxia Yao; George Golovko; Agustin Plasencia; Francisco J Quintana; Liang Zhou; Yanqing Li; Yingzi Cong
Journal:  iScience       Date:  2022-08-24

9.  Expression of Interleukin-26 is upregulated in inflammatory bowel disease.

Authors:  Makoto Fujii; Atsushi Nishida; Hirotsugu Imaeda; Masashi Ohno; Kyohei Nishino; Shigeki Sakai; Osamu Inatomi; Shigeki Bamba; Masahiro Kawahara; Tomoharu Shimizu; Akira Andoh
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

10.  Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease.

Authors:  Daniel C Stewart; Dalton Berrie; Jian Li; Xinyue Liu; Cooper Rickerson; David Mkoji; Atif Iqbal; Sanda Tan; Andria L Doty; Sarah C Glover; Chelsey S Simmons
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.